The liquid injection molding process involves injecting a precisely measured amount of liquid polymer into a heated mold cavity, where it cools and solidifies into the final molded shape. This advanced process enables the mass production of miniature, complex parts with high precision. It is widely utilized in the manufacturing of medical devices like drug-delivery systems, surgical instruments and implants. The global liquid injection molding market exhibits high growth potential attributable to its growing application in these areas.

The global liquid injection molding market is estimated to be valued at US$ 10.77 Bn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

One of the primary drivers for the industry is the increasing demand for minimally invasive medical devices from the healthcare sector. Liquid injection molding facilitates the mass production of intricate, miniature components required in devices like surgical needles, catheters and implant components. It provides design flexibility for complex geometries along with dimensional accuracy and repeatability for high-volume outputs.

Moreover, the process allows for inclusion of additives during molding that can enhance the performance characteristics of end-products. Medical grade polymers incorporating antimicrobial, lubricious or radiopaque properties expand the usability of injection molded components. Ongoing research and development of novel materials suitable for liquid injection molding further expands the repertoire of applications.

SWOT ANALYSIS
Strength: The liquid injection molding market uses sophisticated injection molding technologies and materials that allow for complex geometries and tight tolerances to be produced. This results in highly precise end products with intricate details. Also, the process offers high productivity as it can produce thousands of parts per hour. Additionally, liquid injection molding produces parts with smooth textures and surfaces.

Weakness: The setup and tooling costs for liquid injection molding machines and molds tend to be higher than conventional plastic injection molding. Also, liquid injection molded parts require post-curing to fully harden the materials, which increases production timelines.

Opportunity: The healthcare industry extensively uses liquid injection molding for producing medical devices and pharmaceutical packaging. As populations globally age and chronic diseases rise, the demand for such products will increase significantly in the coming years presenting major opportunities. Additionally, the renewable energy sector is expected to emerge as a key growth area as more solar panels and wind turbine components will need liquid injection molding.

Threats: Volatility in raw material prices especially resins and polymers poses a major threat. Any supply disruptions or price hikes can negatively impact production costs. Also, certain end-use industries like automotive are shifting to 3D printing and other additive technologies for prototyping, which may reduce future demand for liquid injection molding to some extent.

KEY TAKEAWAYS
The global Liquid Injection Molding Market Growth  is expected to witness high growth over the forecast period 2023 to 2030. The market size is projected to reach US$ 15.32 Bn by 2030 from US$ 10.77 Bn in 2023, expanding at a CAGR of 4.6%.

Regional analysis: North America dominates the global liquid injection molding market currently accounting for over 35% share. This is attributed to strong presence of major medical device OEMs in the region. However, Asia Pacific is expected to emerge as the fastest growing market owing to expanding manufacturing industry and rising healthcare spending in countries like China and India. Several key players are also shifting their liquid injection molding operations to Asia Pacific to leverage lower costs.

Key players: Key players operating in the liquid injection molding market are Pfizer, Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., and Sanofi. Pfizer dominates the market with over 20% share through its extensive portfolio of pharmaceutical products in therapy areas like oncology, vaccines, and biosimilars. Roche and Takeda also have significant presence focused on pharmaceuticals and biologics. Regeneron specializes in biotech medicines and Sanofi has a wide range of offerings including vaccines and insulin products.

For more insights, read- https://www.pressreleasebulletin.com/liquid-injection-molding-market-trends-size-and-share-analysis/